Description
Unlock the next generation of T cell manufacturing with NanoSpark®STEM-T activation reagent – engineered to elevate performance, safety, and precision in CAR-T cell therapy. STEM-T drives robust expansion of stem-like CD8+ cells, enhancing clinical efficacy. It is a soluble, protein-based solution – eliminating magnetic components and reducing risks from cytotoxic residues or open handling. Seamlessly integrate into existing GMP workflows and scale with confidence.
Key Benefits:
Anti-CD3/CD28 based, GMP-ready formulation.
High CD8+ yield with stem-like phenotype.
Greater safety vs. traditional bead-based systems.
Compatible with closed, automated platforms.
Maximize your therapy’s potential – from bench to bedside.